Research lines

  • Assessment of toxicity of emerging chemicalsubstances.
  • Development of tools and guidance for CBRN response.
  • Human and environmental biomonitoring of emerging chemical and biological hazards
  • Mass casualty (wet and dry) decontamination and medical countermeasures
  • Pharmaceutical innovation for the developmentof drugs for CBRN response.
  • Risk characterisation and reporting.